Keyphrases
Etanercept
100%
Randomized Controlled Trial
100%
Tumor Necrosis Factor-α
50%
Interleukin-6
25%
Tramadol
25%
Monotherapy
25%
Erythrocyte Sedimentation Rate
25%
Nave
25%
Functional Status
25%
Therapeutic Potential
12%
Pain Assessment
12%
Disease Activity
12%
Trial Registration
12%
Activity Score
12%
Newly Diagnosed
12%
Placebo
12%
TNF Receptor 1 (TNFR1)
12%
Plasma Parameters
12%
Patient Assessment
12%
Health Assessment Questionnaire
12%
Control Subjects
12%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Etanercept
100%
Tumor Necrosis Factor
50%
Interleukin 6
25%
Tramadol
25%
Glucocorticoid
25%
Monotherapy
25%
Functional Status
25%
Placebo
12%
Table Salt
12%
Tumor Necrosis Factor Receptor
12%
Disease Activity
12%
Immunology and Microbiology
Etanercept
100%
Tumor Necrosis Factor
50%
Interleukin 6
25%
Glucocorticoid
25%
Functional Status
25%
Erythrocyte Sedimentation Rate
25%
Rigidity
12%
Tumor Necrosis Factor Receptor
12%
Blood Plasma
12%
Blood Level
12%
Biochemistry, Genetics and Molecular Biology
Etanercept
100%
Tramadol
50%
Erythrocyte Sedimentation Rate
50%
Neuroscience
Etanercept
100%
Tramadol
50%
Medicine and Dentistry
Tramadol
25%
Morning Stiffness
12%